WONGVIPAT; John

Patent Applications and Registrations

Patent applications and USPTO patent grants for WONGVIPAT; John.The latest application filed is for "diarylhydantoin compounds".

Company Profile

2.14.22

WONGVIPAT; John - New York NY
Wongvipat; John - Nanuet NY
Wongvipat; John - Arcadia CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Diarylhydantoin Compounds App 20210238145 - SAWYERS; Charles L. ; et al.	2021-08-05
Androgen Receptor Modulator For The Treatment Of Prostate Cancer And Androgen Receptor-associated Diseases App 20210121450 - Jung; Michael E. ; et al.	2021-04-29
Substituted diazaspiroalkanes as androgen receptor modulators Grant 10,857,139 - Jung , et al. December 8, 2	2020-12-08
Diarylhydantoin Compounds App 20200079741 - SAWYERS; Charles L. ; et al.	2020-03-12
Diarylhydantoin Compounds App 20190210974 - SAWYERS; Charles L. ; et al.	2019-07-11
Androgen Receptor Modulator For The Treatment Of Prostate Cancer And Androgen Receptor-associated Diseases App 20180318276 - Jung; Michael E. ; et al.	2018-11-08
Substituted diazaspiroalkanes as androgen receptor modulators Grant 9,987,261 - Jung , et al. June 5, 2	2018-06-05
Diarylhydantoin Compounds App 20180086718 - Sawyers; Charles L. ; et al.	2018-03-29
Androgen Receptor Modulator For The Treatment Of Prostate Cancer And Androgen Receptor-associated Diseases App 20170014399 - Jung; Michael E. ; et al.	2017-01-19
Substituted diazaspiroalkanes as androgen receptor modulators Grant 9,388,159 - Jung , et al. July 12, 2	2016-07-12
Treatment of hyperproliferative disorders with diarylhydantoin compounds Grant 9,126,941 - Sawyers , et al. September 8, 2	2015-09-08
Diarylhydantoin Compounds App 20150112082 - Sawyers; Charles L. ; et al.	2015-04-23
Diarylhydantoin Compounds App 20150065546 - Jung; Michael E. ; et al.	2015-03-05
Diarylthiohydantoin Compounds App 20140343111 - Sawyers; Charles L. ; et al.	2014-11-20
Androgen Receptor Modulator For The Treatment Of Prostate Cancer And Androgen Receptor-associated Diseases App 20140309262 - Jung; Michael E. ; et al.	2014-10-16
Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases Grant 8,802,689 - Jung , et al. August 12, 2	2014-08-12
Diarylthiohydantoin compounds Grant 8,648,105 - Jung , et al. February 11, 2	2014-02-11
Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases Grant 8,445,507 - Jung , et al. May 21, 2	2013-05-21
Androgen Receptor Modulator For The Treatment Of Prostate Cancer And Androgen Receptor-associated Diseases App 20130072511 - Jung; Michael E. ; et al.	2013-03-21
Diarylhydantoin Compounds App 20130034501 - Sawyers; Charles L. ; et al.	2013-02-07
Treatment Of Hyperproliferative Disorders With Diarylhydantoin Compounds App 20120295944 - Sawyers; Charles L. ; et al.	2012-11-22
Diarylthiohydantoin Compounds App 20120190718 - Jung; Michael E. ; et al.	2012-07-26
Treatment of hyperproliferative disorders with diarylhydantoin compounds Grant 8,183,274 - Sawyers , et al. May 22, 2	2012-05-22
Diarylthiohydantoin compounds Grant 8,110,594 - Jung , et al. February 7, 2	2012-02-07
Androgen Receptor Modulator For The Treatment Of Prostate Cancer And Androgen Receptor-associated Diseases App 20110003839 - Jung; Michael E. ; et al.	2011-01-06
Diarylhydantoin Compounds App 20100210665 - Sawyers; Charles L. ; et al.	2010-08-19
Treatment Of Hyperproliferative Disorders With Diarylhydantoin Compounds App 20100172975 - Sawyers; Charles L. ; et al.	2010-07-08
Diarylhydantoin compounds Grant 7,709,517 - Sawyers , et al. May 4, 2	2010-05-04
Diarylhydantoin compounds App 20070004753 - Sawyers; Charles L. ; et al.	2007-01-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.